About
Jana Buzkova is the COO and co-founder of Finnish biotech company NADMED, which commercializes NAD and glutathione measurement technology originating from University of Helsinki research. Earlier University of Helsinki materials described her as a project planning officer, project manager, and future company COO/commercial liaison in the spinout's formation. Her work sits at the intersection of metabolic health, diagnostics, and personalized medicine, with a clear relevance to aging and longevity applications.
Areas of interest
biotechdiagnosticsmetabolic healthredox biologypersonalized medicinelongevityaging-related disease